NCT06803966

Brief Summary

patients undergoing laparoscopic cholecystectomy will be diveided into 2 groups A \& B . Group A will receive local anesthetic wound infiltration and group B will receive Transversus abdominal plane block as a post operative analgesia. the time for request of first rescue analgesia between the 2 groups will be compared

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
74

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Aug 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 5, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 11, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 11, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 22, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 31, 2025

Completed
Last Updated

January 31, 2025

Status Verified

January 1, 2025

Enrollment Period

5 months

First QC Date

January 22, 2025

Last Update Submit

January 28, 2025

Conditions

Keywords

transversus abdominal plane blocklocal anesthetic wound infiltration

Outcome Measures

Primary Outcomes (1)

  • first rescue analgesia

    time of requirement of first rescue analgesia will be compared between group a and group b

    from enrollment to 24 hours post operation

Study Arms (2)

Group A: local anesthetic infiltration at port sites

ACTIVE COMPARATOR

Group A patient's will receive local anesthetic wound infiltration at port sites with inj Bupivacaine (Bupivacaine Hydrochloride) 0.5%

Other: Post Operative Analgesia

Group B : TAP block

ACTIVE COMPARATOR

Group b will receive Transversus Abdominal Plane (TAP) block at both sides using inj bupivacaine (Bupivacaine Hydrochloride) 0.25%

Other: Post Operative Analgesia

Interventions

Group A will receive local wound infiltration at port sites with inj bupivacaine (bupivacaine Hydrochloride) 0.5 % Group B will receive Transversus Abdominal Plane Block on both sides by inj bupivacaine (bupivacaine Hydrochloride) 0.25%

Also known as: Group A : local wound infiltration, Group B : TAP block
Group A: local anesthetic infiltration at port sitesGroup B : TAP block

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • both gender patients undergoing elective laparoscopic cholecystectomy ASA physical status classification 1 \& 2

You may not qualify if:

  • patients with chronic pain patients unable to understand NRS pain scale conversion of laparoscopic to open cholecystectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

PAF hospital Faisal base

Karachi, Sindh, 20006, Pakistan

Location

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: group A will get local ansthetic wound infiltration at port site and Group b will get Transversus abdominal plane block
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 22, 2025

First Posted

January 31, 2025

Study Start

August 5, 2024

Primary Completion

January 11, 2025

Study Completion

January 11, 2025

Last Updated

January 31, 2025

Record last verified: 2025-01

Locations